Tapewire

Nasdaq · USD

YARW

Yarrow Bioscience, Inc.

Export transactions ↓
Tapewire entity
6871
SEC CIK
0001566044
Parsed reports
325

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 12, 2024 Filed Dec 13, 2024 16:15 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $2.40 $0.00
Disclosure

SEC source: 0001415889-24-029286 · form4-12132024_041207.xml · derivative · entry 1

Bruno Anthony D · CIK 0001374180 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2034-12-11

F1 · derivative.exercise_date: Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2025, subject to the Reporting Person's continuous service through such date.

Read SEC document
December 12, 2024 Filed Dec 13, 2024 16:15 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $2.40 $0.00
Disclosure

SEC source: 0001415889-24-029289 · form4-12132024_041213.xml · derivative · entry 1

BARBARI SHARON · CIK 0001240499 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2034-12-11

F1 · derivative.exercise_date: Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2025, subject to the Reporting Person's continuous service through such date.

Read SEC document
December 12, 2024 Filed Dec 13, 2024 21:15 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $2.40 $0.00
Disclosure

SEC source: 0001415889-24-029291 · form4-12132024_041217.xml · derivative · entry 1

Borowski Christine · CIK 0002005073 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2034-12-11

F1 · derivative.exercise_date: Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2025, subject to the Reporting Person's continuous service through such date.

Read SEC document
December 12, 2024 Filed Dec 13, 2024 21:15 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $2.40 $0.00
Disclosure

SEC source: 0001415889-24-029287 · form4-12132024_041209.xml · derivative · entry 1

Sandoval Elisabeth · CIK 0001632295 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2034-12-11

F1 · derivative.exercise_date: Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2025, subject to the Reporting Person's continuous service through such date.

Read SEC document
November 30, 2024 Filed Dec 3, 2024 21:15 UTC
Domzalski DavidDirector · PRESIDENT AND CEO
GrantCommon Stock 3,901 $2.10 $8,192.10
Disclosure

SEC source: 0001415889-24-028073 · form4-12032024_041201.xml · nonDerivative · entry 1

Domzalski David · CIK 0001727794 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,597

F1 · kind: These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on June 1, 2024 and ending on November 30, 2024 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on June 3, 2024 (the first trading day of the offering period). The Reporting Person purchased the maximum number of shares permitted by the terms of the ESPP during the calendar year.

Read SEC document
September 30, 2024 Filed Oct 2, 2024 20:15 UTC
Zeronda TylerCHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 84 $1.88 $157.92
Disclosure

SEC source: 0001415889-24-024383 · form4-10022024_041008.xml · nonDerivative · entry 1

Zeronda Tyler · CIK 0001867033 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,567

F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
September 30, 2024 Filed Oct 2, 2024 20:15 UTC
Stuart IainCHIEF SCIENTIFIC OFFICER
Tax withholdingCommon Stock 109 $1.88 $204.92
Disclosure

SEC source: 0001415889-24-024382 · form4-10022024_041005.xml · nonDerivative · entry 1

Stuart Iain · CIK 0001727756 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,494

F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
September 30, 2024 Filed Oct 2, 2024 20:15 UTC
Domzalski DavidDirector · PRESIDENT AND CEO
Tax withholdingCommon Stock 685 $1.88 $1,287.80
Disclosure

SEC source: 0001415889-24-024380 · form4-10022024_041001.xml · nonDerivative · entry 1

Domzalski David · CIK 0001727794 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 496,696

F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
September 30, 2024 Filed Oct 2, 2024 20:15 UTC
Harsch MutyaCHIEF LEGAL OFFICER AND GC
Tax withholdingCommon Stock 105 $1.88 $197.40
Disclosure

SEC source: 0001415889-24-024381 · form4-10022024_041004.xml · nonDerivative · entry 1

Harsch Mutya · CIK 0001727809 · CHIEF LEGAL OFFICER AND GC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,026

F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
July 01, 2024 Filed Jul 3, 2024 20:15 UTC
Zeronda TylerCHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 92 $1.92 $176.64
Disclosure

SEC source: 0001415889-24-019176 · form4-07032024_040715.xml · nonDerivative · entry 1

Zeronda Tyler · CIK 0001867033 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,651

F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
July 01, 2024 Filed Jul 3, 2024 20:15 UTC
Stuart IainCHIEF SCIENTIFIC OFFICER
Tax withholdingCommon Stock 138 $1.92 $264.96
Disclosure

SEC source: 0001415889-24-019175 · form4-07032024_040713.xml · nonDerivative · entry 1

Stuart Iain · CIK 0001727756 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,603

F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
July 01, 2024 Filed Jul 3, 2024 20:15 UTC
Harsch MutyaCHIEF LEGAL OFFICER AND GC
Tax withholdingCommon Stock 143 $1.92 $274.56
Disclosure

SEC source: 0001415889-24-019174 · form4-07032024_040711.xml · nonDerivative · entry 1

Harsch Mutya · CIK 0001727809 · CHIEF LEGAL OFFICER AND GC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,131

F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
July 01, 2024 Filed Jul 3, 2024 20:15 UTC
Domzalski DavidDirector · PRESIDENT AND CEO
Tax withholdingCommon Stock 935 $1.92 $1,795.20
Disclosure

SEC source: 0001415889-24-019173 · form4-07032024_040709.xml · nonDerivative · entry 1

Domzalski David · CIK 0001727794 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 497,654

F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:30 UTC
Domzalski DavidDirector · PRESIDENT AND CEO
GrantCommon Stock 4,429 $2.16 $9,562.21
Disclosure

SEC source: 0001415889-24-015370 · form4-06042024_040620.xml · nonDerivative · entry 1

Domzalski David · CIK 0001727794 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 498,589

F1 · shares: These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2023 and ending on May 31, 2024 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on May 31, 2024.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:08 UTC
Zeronda TylerCHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 94 $3.08 $289.52
Disclosure

SEC source: 0001415889-24-010074 · form4-04032024_090450.xml · nonDerivative · entry 1

Zeronda Tyler · CIK 0001867033 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,743

F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:06 UTC
Stuart IainCHIEF SCIENTIFIC OFFICER
Tax withholdingCommon Stock 157 $3.08 $483.56
Disclosure

SEC source: 0001415889-24-010070 · form4-04032024_090410.xml · nonDerivative · entry 1

Stuart Iain · CIK 0001727756 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,741

F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:04 UTC
Harsch MutyaCHIEF LEGAL OFFICER AND GC
Tax withholdingCommon Stock 161 $3.08 $495.88
Disclosure

SEC source: 0001415889-24-010067 · form4-04032024_090429.xml · nonDerivative · entry 1

Harsch Mutya · CIK 0001727809 · CHIEF LEGAL OFFICER AND GC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,274

F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:02 UTC
Domzalski DavidDirector · PRESIDENT AND CEO
Tax withholdingCommon Stock 1,004 $3.08 $3,092.32
Disclosure

SEC source: 0001415889-24-010064 · form4-04032024_090445.xml · nonDerivative · entry 1

Domzalski David · CIK 0001727794 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 494,160

F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 22:22 UTC
Zeronda TylerChief Financial Officer
Tax withholdingCommon Stock 93 $2.28 $212.04
Disclosure

SEC source: 0001209191-24-000470 · doc4.xml · nonDerivative · entry 2

Zeronda Tyler · CIK 0001867033 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,837

F3 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 22:21 UTC
Stuart IainChief Scientific Officer
Tax withholdingCommon Stock 157 $2.28 $357.96
Disclosure

SEC source: 0001209191-24-000469 · doc4.xml · nonDerivative · entry 2

Stuart Iain · CIK 0001727756 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,898

F3 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 22:20 UTC
Harsch MutyaChief Legal Officer and GC
Tax withholdingCommon Stock 161 $2.28 $367.08
Disclosure

SEC source: 0001209191-24-000467 · doc4.xml · nonDerivative · entry 2

Harsch Mutya · CIK 0001727809 · Chief Legal Officer and GC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,435

F3 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 22:17 UTC
Domzalski DavidDirector · President and CEO
Tax withholdingCommon Stock 1,004 $2.28 $2,289.12
Disclosure

SEC source: 0001209191-24-000465 · doc4.xml · nonDerivative · entry 2

Domzalski David · CIK 0001727794 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 495,164

F3 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 17:13 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $2.33 $0.00
Disclosure

SEC source: 0001209191-24-000462 · doc4.xml · derivative · entry 1

LEPORE PATRICK G · CIK 0001055404 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-12-31

F1 · derivative.exercise_date: The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 17:10 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $2.33 $0.00
Disclosure

SEC source: 0001209191-24-000460 · doc4.xml · derivative · entry 1

Basta Steven L · CIK 0001417397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-12-31

F1 · derivative.exercise_date: The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 17:11 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $2.33 $0.00
Disclosure

SEC source: 0001209191-24-000461 · doc4.xml · derivative · entry 1

Bruno Anthony D · CIK 0001374180 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-12-31

F1 · derivative.exercise_date: The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 17:09 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $2.33 $0.00
Disclosure

SEC source: 0001209191-24-000459 · doc4.xml · derivative · entry 1

BARBARI SHARON · CIK 0001240499 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-12-31

F1 · derivative.exercise_date: The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 22:22 UTC
Zeronda TylerChief Financial Officer
GrantStock Option (right to buy) · Derivative 62,500 $0.00 Strike: $2.33 $0.00
Disclosure

SEC source: 0001209191-24-000470 · doc4.xml · derivative · entry 3

Zeronda Tyler · CIK 0001867033 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2033-12-31

F4 · derivative.exercise_date: The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 22:22 UTC
Zeronda TylerChief Financial Officer
GrantCommon Stock 62,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-000470 · doc4.xml · nonDerivative · entry 1

Zeronda Tyler · CIK 0001867033 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,930

F1 · shares: Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

F2 · shares: The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 22:21 UTC
Stuart IainChief Scientific Officer
GrantStock Option (right to buy) · Derivative 62,500 $0.00 Strike: $2.33 $0.00
Disclosure

SEC source: 0001209191-24-000469 · doc4.xml · derivative · entry 3

Stuart Iain · CIK 0001727756 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2033-12-31

F4 · derivative.exercise_date: The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 22:21 UTC
Stuart IainChief Scientific Officer
GrantCommon Stock 62,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-000469 · doc4.xml · nonDerivative · entry 1

Stuart Iain · CIK 0001727756 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,055

F1 · shares: Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

F2 · shares: The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 22:20 UTC
Harsch MutyaChief Legal Officer and GC
GrantStock Option (right to buy) · Derivative 62,500 $0.00 Strike: $2.33 $0.00
Disclosure

SEC source: 0001209191-24-000467 · doc4.xml · derivative · entry 3

Harsch Mutya · CIK 0001727809 · Chief Legal Officer and GC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2033-12-31

F4 · derivative.exercise_date: The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 22:20 UTC
Harsch MutyaChief Legal Officer and GC
GrantCommon Stock 62,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-000467 · doc4.xml · nonDerivative · entry 1

Harsch Mutya · CIK 0001727809 · Chief Legal Officer and GC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,596

F1 · shares: Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

F2 · shares: The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 22:17 UTC
Domzalski DavidDirector · President and CEO
GrantStock Option (right to buy) · Derivative 225,000 $0.00 Strike: $2.33 $0.00
Disclosure

SEC source: 0001209191-24-000465 · doc4.xml · derivative · entry 3

Domzalski David · CIK 0001727794 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,000

Underlying: Common Stock · 225,000 shares

Expires 2033-12-31

F4 · derivative.exercise_date: The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 22:17 UTC
Domzalski DavidDirector · President and CEO
GrantCommon Stock 225,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-000465 · doc4.xml · nonDerivative · entry 1

Domzalski David · CIK 0001727794 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 496,168

F1 · shares: Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

F2 · shares: The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 22:14 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $2.33 $0.00
Disclosure

SEC source: 0001209191-24-000463 · doc4.xml · derivative · entry 1

Sandoval Elisabeth · CIK 0001632295 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-12-31

F1 · derivative.exercise_date: The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 22:07 UTC GrantStock Option (right to buy) · Derivative 40,000 $0.00 Strike: $2.33 $0.00
Disclosure

SEC source: 0001209191-24-000456 · doc4.xml · derivative · entry 1

Borowski Christine · CIK 0002005073 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2033-12-31

F1 · derivative.exercise_date: The option will vest and become exercisable as to 1/3rd of the shares subject to the option on each annual anniversary of the date of grant, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 17:05 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $2.70 $0.00
Disclosure

SEC source: 0001209191-23-058812 · doc4.xml · derivative · entry 1

LEPORE PATRICK G · CIK 0001055404 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-12-12

F1 · derivative.exercise_date: Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest on December 13, 2024, subject to the Reporting Person's continuous service through such date.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 17:02 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $2.70 $0.00
Disclosure

SEC source: 0001209191-23-058809 · doc4.xml · derivative · entry 1

Basta Steven L · CIK 0001417397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-12-12

F1 · derivative.exercise_date: Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest on December 13, 2024, subject to the Reporting Person's continuous service through such date.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 17:04 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $2.70 $0.00
Disclosure

SEC source: 0001209191-23-058811 · doc4.xml · derivative · entry 1

Bruno Anthony D · CIK 0001374180 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-12-12

F1 · derivative.exercise_date: Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest on December 13, 2024, subject to the Reporting Person's continuous service through such date.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 17:01 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $2.70 $0.00
Disclosure

SEC source: 0001209191-23-058807 · doc4.xml · derivative · entry 1

BARBARI SHARON · CIK 0001240499 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-12-12

F1 · derivative.exercise_date: Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest on December 13, 2024, subject to the Reporting Person's continuous service through such date.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 22:11 UTC
Zeronda TylerChief Financial Officer
GrantStock Option (right to buy) · Derivative 62,500 $0.00 Strike: $2.70 $0.00
Disclosure

SEC source: 0001209191-23-058819 · doc4.xml · derivative · entry 2

Zeronda Tyler · CIK 0001867033 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2033-12-12

F3 · derivative.exercise_date: The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 22:11 UTC
Zeronda TylerChief Financial Officer
GrantCommon Stock 62,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-058819 · doc4.xml · nonDerivative · entry 1

Zeronda Tyler · CIK 0001867033 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,430

F1 · shares: Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

F2 · shares: The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 22:10 UTC
Stuart IainChief Scientific Officer
GrantStock Option (right to buy) · Derivative 62,500 $0.00 Strike: $2.70 $0.00
Disclosure

SEC source: 0001209191-23-058818 · doc4.xml · derivative · entry 2

Stuart Iain · CIK 0001727756 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2033-12-12

F3 · derivative.exercise_date: The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 22:10 UTC
Stuart IainChief Scientific Officer
GrantCommon Stock 62,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-058818 · doc4.xml · nonDerivative · entry 1

Stuart Iain · CIK 0001727756 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,555

F1 · shares: Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

F2 · shares: The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 22:09 UTC
Harsch MutyaChief Legal Officer and GC
GrantStock Option (right to buy) · Derivative 62,500 $0.00 Strike: $2.70 $0.00
Disclosure

SEC source: 0001209191-23-058817 · doc4.xml · derivative · entry 2

Harsch Mutya · CIK 0001727809 · Chief Legal Officer and GC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2033-12-12

F3 · derivative.exercise_date: The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 22:09 UTC
Harsch MutyaChief Legal Officer and GC
GrantCommon Stock 62,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-058817 · doc4.xml · nonDerivative · entry 1

Harsch Mutya · CIK 0001727809 · Chief Legal Officer and GC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,096

F1 · shares: Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

F2 · shares: The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 22:08 UTC
Domzalski DavidDirector · President and CEO
GrantStock Option (right to buy) · Derivative 225,000 $0.00 Strike: $2.70 $0.00
Disclosure

SEC source: 0001209191-23-058815 · doc4.xml · derivative · entry 2

Domzalski David · CIK 0001727794 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,000

Underlying: Common Stock · 225,000 shares

Expires 2033-12-12

F3 · derivative.exercise_date: The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 22:08 UTC
Domzalski DavidDirector · President and CEO
GrantCommon Stock 225,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-058815 · doc4.xml · nonDerivative · entry 1

Domzalski David · CIK 0001727794 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 271,168

F1 · shares: Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

F2 · shares: The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 22:06 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $2.70 $0.00
Disclosure

SEC source: 0001209191-23-058813 · doc4.xml · derivative · entry 1

Sandoval Elisabeth · CIK 0001632295 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-12-12

F1 · derivative.exercise_date: Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest on December 13, 2024, subject to the Reporting Person's continuous service through such date.

Read SEC document
November 30, 2023 Filed Dec 4, 2023 21:30 UTC
Domzalski DavidDirector · President and CEO
GrantCommon Stock 2,284 $2.81 $6,426.03
Disclosure

SEC source: 0001209191-23-057220 · doc4.xml · nonDerivative · entry 1

Domzalski David · CIK 0001727794 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,168

F1 · shares: These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on June 1, 2023 and ending on November 30, 2023 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on November 30, 2023 (the last trading day of the offering period). The reporting person purchased the maximum number of shares permitted by the terms of the ESPP during the calendar year.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.